Reuters logo
BRIEF-Lansen Pharma updates on litigation against Ningbo Liwah unit
September 1, 2017 / 2:15 PM / 4 months ago

BRIEF-Lansen Pharma updates on litigation against Ningbo Liwah unit

Sept 1 (Reuters) - Lansen Pharma:

* Ningbo Liwah received judgment delivered by Shenzhen Intermediate People’s Court of People’s Republic of China

* Ningbo Liwah is ordered to pay an amount of about RMB30 million

* Claimant had alleged it suffered certain losses due to use of Ginkgo Extract supplied by Ningbo Liwah in claimant’s products Source text: (bit.ly/2wsWK6j) Further company coverage: (bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below